Search Results - "Chien, R.‐N."

Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update by Sarin, S. K., Kumar, M., Lau, G. K., Abbas, Z., Chan, H. L. Y., Chen, C. J., Chen, D. S., Chen, H. L., Chen, P. J., Chien, R. N., Dokmeci, A. K., Gane, Ed, Hou, J. L., Jafri, W., Jia, J., Kim, J. H., Lai, C. L., Lee, H. C., Lim, S. G., Liu, C. J., Locarnini, S., Al Mahtab, M., Mohamed, R., Omata, M., Park, J., Piratvisuth, T., Sharma, B. C., Sollano, J., Wang, F. S., Wei, L., Yuen, M. F., Zheng, S. S., Kao, J. H.

“…Worldwide, some 240 million people have chronic hepatitis B virus (HBV), with the highest rates of infection in Africa and Asia. Our understanding of the…”
Get full text

Efficacy and safety of ribavirin plus pegylated interferon alfa in geriatric patients with chronic hepatitis C by Hu, C.‐C., Lin, C.‐L., Kuo, Y.‐L., Chien, C.‐H., Chen, S.‐W., Yen, C.‐L., Lin, C.‐Y., Chien, R.‐N.

“…Summary Background Limited data are available on the efficacy and safety of antiviral therapy in geriatric patients with chronic hepatitis C virus (HCV)…”
Get full text

Commentary: efficacy and safety of ribavirin plus pegylated interferon‐alpha in geriatric patients with chronic hepatitis C – authors’ reply by Hu, C.‐C., Chien, R.‐N.

Get full text

Comparison of the once-daily levofloxacin-containing triple therapy with the twice-daily standard triple therapy for first-line Helicobacter pylori eradication: a prospective randomised study by Chen, L-W, Chien, R-N, Chang, J-J, Fang, K-M, Chang, L-C

“…Simple compound of Helicobacter pylori eradication therapy may improve drug compliance of patients. The aims of this study were to compare the efficacy and…”
Get more information

Chronic hepatitis B virus infection in Asian countries by Merican, I, Guan, R, Amarapuka, D, Alexander, Mj, Chutaputti, A, Chien, Rn, Hasnian, Ss, Leung, N, Lesmana, L, Phiet, Ph, Sjalfoellah Noer, Hm, Sollano, J, Sun, Hs, Xu, Dz

“…Of the estimated 50 million new cases of hepatitis B virus (HBV) infection diagnosed annually, 5–10% of adults and up to 90% of infants will become chronically…”
Get full text

Switching to adefovir monotherapy after emergence of lamivudine-resistant mutations in patients with liver cirrhosis by Liaw, Y.-F., Lee, C.-M., Chien, R.-N., Yeh, C.-T.

“…Switching to adefovir (ADV) monotherapy is effective in patients with lamivudine (LAM)‐resistant hepatitis B virus (HBV) mutations (rtM204 I/V). However, it…”
Get full text

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy by Liaw, Yun‐Fan, Chien, Rong‐Nan, Yeh, Chau‐Ting, Tsai, Sun‐Lung, Chu, Chia‐Ming

“…Lamivudine is a potent inhibitor of hepatitis B virus (HBV) replication, but its long‐term use may be associated with HBV…”
Get full text

Long‐term beneficial effect of interferon therapy in patients with chronic hepatitis B virus infection by Lin, Shi‐Ming, Sheen, I‐Shyan, Chien, Rong‐Nan, Chu, Chia‐Ming, Liaw, Yun‐Fan

“…To examine the long‐term effect of interferon (IFN) therapy in patients with chronic hepatitis B virus (HBV) infection, particularly on survival and…”
Get full text

Comparison of long-term effects of lymphoblastoid interferon alpha and recombinant interferon alpha-2a therapy in patients with chronic hepatitis B by Lin, S.-M., Tai, D.-I., Chien, R.-N., Sheen, I.-S., Chu, C.-M., Liaw, Y.-F.

“…To compare the long‐term effect of natural lymphoblastoid interferon‐alpha (IFN‐αnl) and recombinant IFN‐α2a therapy in patients with chronic hepatitis B, 210…”
Get full text

Clinical outcomes after interruption of entecavir therapy in HBeAg‐negative chronic hepatitis B patients with compensated cirrhosis by Chen, Y. C., Peng, C. Y., Jeng, W. J., Chien, R. N., Liaw, Y. F.

“…Summary Background Long‐term nucleos(t)ide analogues therapy may reduce hepatocellular carcinoma (HCC) in chronic hepatitis B patients with advanced fibrosis…”
Get full text

Liver injury is associated with enhanced regulatory T-cell activity in patients with chronic hepatitis B by Lin, C.-Y., Tsai, M.-C., Huang, C.-T., Hsu, C.-W., Tseng, S.-C., Tsai, I.-F., Chen, Y.-C., Yeh, C.-T., Sheen, I.-S., Chien, R.-N.

“…Chronic hepatitis B virus (HBV) infection is associated with impairment of HBV‐specific immune responses. Recently, it has been shown that regulatory T (Treg)…”
Get full text

Clinical outcomes after spontaneous and nucleos(t)ide analogue‐treated HBsAg seroclearance in chronic HBV infection by Chen, Y. C., Jeng, W. J., Chien, R. N., Chu, C. M., Liaw, Y. F.

“…Summary Background Both spontaneous and nucleos(t)ide analogue (Nuc)‐treated hepatitis B surface antigen (HBsAg) seroclearance are associated with excellent…”
Get full text

Hepatitis B virus genotype B is associated with better response to thymosin α1 therapy than genotype C by Chien, R-N., Lin, C-Y., Yeh, C-T., Liaw, Y-F.

“…Hepatitis B virus (HBV) genotype has been reported to correlate with response to interferon treatment in several studies. The relationship between HBV genotype…”
Get full text

Hepatitis B virus genotype B is associated with better response to thymosin α 1 therapy than genotype C by Chien, R‐N., Lin, C‐Y., Yeh, C‐T., Liaw, Y‐F.

“…Hepatitis B virus (HBV) genotype has been reported to correlate with response to interferon treatment in several studies. The relationship between HBV genotype…”
Get full text

Splenic tumour: a clinicopathological study by Chen, L W, Chien, R N, Yen, C L, Chang, L C

“…Splenic tumours are occasionally found during routine physical check-ups or elective abdominal image studies. Histologically, most splenic tumours are of…”
Get more information

Solitary actinomycotic abscesses of liver: report of two cases by Chen, L-W, Chang, L-C, Shie, S-S, Chien, R-N

“…Hepatic actinomycotic abscesses are rare and secondary to other intra-abdominal infections. History of intra-abdominal surgery is a principal contributing…”
Get more information

Elucidating therapeutic effects on patients with hepatocellular carcinoma and main portal vein thrombosis by Chen, L W, Chien, R N, Fang, K M, Yen, C L, Chang, J J, Lee, T S, Liu, C J

“…The survival duration for patients diagnosed with hepatocellular carcinoma (HCC) with main portal vein thrombosis (MPVT) was usually less than 3 months. The…”
Get more information

High frequency of functional anti-YMDD and -mutant cytotoxic T lymphocytes after in vitro expansion correlates with successful response to lamivudine therapy for chronic hepatitis B by Lin, C-L, Tsai, S-L, Lee, T-H, Chien, R-N, Liao, S-K, Liaw, Y-F

“…Background: Many determinants for a sustained response to lamivudine therapy have been reported but the role of T cell responsiveness remains unclear. The…”
Get full text

Unintentional rechallenge resulting in a causative relationship between ketoconazole and acute liver injury by Chien, R N, Sheen, I S, Liaw, Y F

“…We present the case of a female patient in whom acute overt hepatitis developed after 60 days of ketoconazole administration (200 mg/day). A prompt renewed…”
Get more information

Prednisolone Priming Enhances Th1 Response and Efficacy of Subsequent Lamivudine Therapy in Patients With Chronic Hepatitis B by Liaw, Yun-Fan, Tsai, Sun-Lung, Chien, Rong-Nan, Yeh, Chau-Ting, Chu, Chia-Ming

“…Asian lamivudine trial has shown that hepatitis B e antigen (HBeAg) seroconversion rate during 1 year of lamivudine therapy was only 16% but was 64% in the…”
Get full text